All 255 IBB (ISHARES BIOTECHNOLOGY ETF) Holdings
There are 255 IBB holdings. Top 10 companies weight: 45.35%.
Total Market Cap: $1.46T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (255 stocks) | +21.29% | 22.10 | 16.14 | 0.50 | +43.28% | +8.52% | 0.87 | ||||||||||
1 | GILD | Gilead Sciences Inc | 7.60% | $127.57 | $166B | Drug Manufacturers - General | Healthcare | +98.59% | 18.01 | 15.22 | 0.33 | N/A | N/A | N/A | N/A | N/A | +18.23% | N/A |
2 | AMGN | Amgen Inc | 7.37% | $328.26 | $181B | Drug Manufacturers - General | Healthcare | +3.49% | 23.21 | 14.79 | 0.75 | N/A | N/A | 60 | +7.30% | $352 | +10.27% | 0.48 |
3 | VRTX | Vertex Pharmaceuticals Inc | 7.37% | $425.09 | $111B | Biotechnology | Healthcare | +9.89% | 25.66 | 23.04 | 1.64 | N/A | N/A | 74 | +29.08% | $549 | +15.02% | 0.51 |
4 | REGN | Regeneron Pharmaceuticals Inc | 6.07% | $602.92 | $65B | Biotechnology | Healthcare | +20.31% | 14.98 | 13.39 | 83.17 | N/A | N/A | 72 | +38.21% | $833 | +3.75% | 0.64 |
5 | ALNY | Alnylam Pharmaceuticals Inc | 3.65% | $286.12 | $39B | Biotechnology | Healthcare | N/A | 124.93 | 31.65 | 0.51 | N/A | N/A | 74 | +55.81% | $446 | +14.20% | 0.82 |
6 | ARGX | Argenx Se Adr | 3.45% | $802.17 | $54B | Biotechnology | Healthcare | N/A | 23.07 | 31.25 | 0.20 | N/A | N/A | 78 | +28.65% | $1.03K | +24.67% | 0.48 |
7 | BIIB | Biogen Inc | 2.65% | $188.83 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.38 | 14.04 | 0.64 | N/A | N/A | 63 | +16.21% | $219 | -7.08% | 0.54 |
8 | NTRA | Natera Inc | 2.50% | $212.73 | $29B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +22.64% | $261 | +17.58% | 1.34 |
9 | RVMD | Revolution Medicines Inc Ordinary Shares | 2.44% | $151.31 | $31B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +22.61% | $186 | +38.07% | 1.07 |
10 | UTHR | United Therapeutics Corp | 2.25% | $540.05 | $24B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 19.28 | 19.88 | 2.05 | N/A | N/A | 71 | +23.18% | $665 | +25.24% | 0.45 |
11 | INSM | Insmed Inc | 2.11% | $103.73 | $23B | Biotechnology | Healthcare | +12.24% | N/A | 16.37 | 1.09 | N/A | N/A | 79 | +92.81% | $200 | +32.74% | 0.74 |
12 | ONC | Beone Medicines Ltd Adr | 2.06% | $274.69 | $35B | Biotechnology | Healthcare | N/A | 67.03 | 46.73 | N/A | N/A | N/A | 81 | +49.81% | $412 | -4.72% | 0.53 |
13 | ILMN | Illumina Inc | 2.00% | $162.55 | $22B | Diagnostics & Research | Healthcare | -6.57% | 34.97 | 31.15 | 2.63 | N/A | N/A | 58 | -11.52% | $144 | -16.21% | 1.03 |
14 | INCY | Incyte Corp | 1.79% | $92.24 | $20B | Biotechnology | Healthcare | +27.16% | 13.38 | 12.41 | N/A | N/A | N/A | 58 | +17.04% | $108 | +2.16% | 0.62 |
15 | MRNA | Moderna Inc | 1.58% | $45.64 | $19B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 48 | -5.35% | $43 | -25.22% | 1.37 |
16 | NBIX | Neurocrine Biosciences Inc | 1.43% | $154.84 | $16B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 23.29 | 22.73 | 0.19 | N/A | N/A | 75 | +24.11% | $192 | +10.45% | 0.82 |
17 | ROIV | Roivant Sciences Ltd Ordinary Shares | 1.37% | $28.25 | $21B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +38.19% | $39 | 0.00% | 0.92 |
18 | GMAB | Genmab As Adr | 1.20% | $23.85 | $17B | Biotechnology | Healthcare | -12.66% | 40.20 | 15.53 | 1.75 | N/A | N/A | N/A | N/A | N/A | -10.11% | N/A |
19 | EXEL | Exelixis Inc | 1.18% | $48.54 | $13B | Biotechnology | Healthcare | +72.24% | 15.79 | 15.92 | 0.41 | N/A | N/A | 61 | +2.29% | $50 | +16.95% | 0.55 |
20 | IONS | Ionis Pharmaceuticals Inc | 1.14% | $72.97 | $13B | Biotechnology | Healthcare | -21.44% | N/A | 90.91 | N/A | N/A | N/A | 78 | +38.30% | $101 | +16.01% | 0.74 |
21 | BBIO | Bridgebio Pharma Inc | 1.07% | $63.88 | $13B | Biotechnology | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 80 | +60.69% | $103 | +1.67% | 1.09 |
22 | ASND | Ascendis Pharma As | 1.05% | $216.60 | $15B | Biotechnology | Healthcare | N/A | 26.35 | 12.38 | N/A | N/A | N/A | 80 | +37.79% | $298 | +10.61% | 0.45 |
23 | MDGL | Madrigal Pharmaceuticals Inc | 1.01% | $452.86 | $12B | Biotechnology | Healthcare | +23.26% | N/A | 666.67 | N/A | N/A | N/A | 76 | +50.00% | $679 | +34.53% | 0.74 |
24 | BMRN | Biomarin Pharmaceutical Inc | 0.96% | $53.32 | $10B | Biotechnology | Healthcare | -20.33% | 37.51 | 11.05 | 0.64 | N/A | N/A | 75 | +64.76% | $88 | -7.17% | 0.70 |
25 | AXSM | Axsome Therapeutics Inc | 0.94% | $222.16 | $12B | Biotechnology | Healthcare | +6.89% | N/A | 333.33 | N/A | N/A | N/A | 77 | +21.66% | $270 | +29.20% | 0.68 |
26 | ARWR | Arrowhead Pharmaceuticals Inc | 0.92% | $70.82 | $11B | Biotechnology | Healthcare | +15.23% | N/A | 111.11 | N/A | N/A | N/A | 77 | +24.50% | $88 | -0.47% | 1.65 |
27 | MEDP | Medpace Holdings Inc | 0.92% | $445.59 | $12B | Diagnostics & Research | Healthcare | +29.42% | 26.32 | 26.81 | 1.35 | N/A | N/A | 55 | -0.62% | $443 | +21.44% | 1.06 |
28 | CYTK | Cytokinetics Inc | 0.86% | $70.91 | $9.51B | Biotechnology | Healthcare | +27.73% | N/A | 117.65 | N/A | N/A | N/A | N/A | N/A | N/A | +27.51% | N/A |
29 | PRAX | N/A | 0.84% | $258.08 | $9.95B | Biotechnology | Healthcare | -18.18% | N/A | N/A | N/A | N/A | N/A | 73 | +152.70% | $652 | -1.55% | 0.90 |
30 | HALO | Halozyme Therapeutics Inc | 0.74% | $66.28 | $8.14B | Biotechnology | Healthcare | +20.06% | 23.20 | 9.43 | N/A | N/A | N/A | 69 | +26.58% | $84 | +11.28% | 0.64 |
31 | CRL | N/A | 0.73% | $174.67 | $7.92B | Diagnostics & Research | Healthcare | N/A | N/A | 16.37 | N/A | N/A | N/A | 67 | +21.53% | $212 | -12.04% | 1.41 |
32 | KRYS | Krystal Biotech Inc | 0.71% | $293.21 | $9.03B | Biotechnology | Healthcare | N/A | 39.70 | 43.67 | 0.50 | N/A | N/A | 72 | +10.08% | $323 | +36.38% | 0.97 |
33 | TECH | Bio-techne Corp | 0.70% | $49.77 | $7.53B | Biotechnology | Healthcare | -10.07% | 68.59 | 25.32 | 0.66 | N/A | N/A | N/A | N/A | N/A | -12.94% | N/A |
34 | BNTX | Biontech Se Adr | 0.69% | $89.14 | $24B | Biotechnology | Healthcare | N/A | N/A | 7.04 | N/A | N/A | N/A | 69 | +39.17% | $124 | -15.79% | 0.95 |
35 | PCVX | Vaxcyte Inc Ordinary Shares | 0.62% | $47.41 | $7.36B | Biotechnology | Healthcare | +33.90% | N/A | N/A | N/A | N/A | N/A | 75 | +129.91% | $109 | +16.51% | 0.73 |
36 | RGEN | Repligen Corp | 0.57% | $121.13 | $6.38B | Medical Instruments & Supplies | Healthcare | +9.09% | 123.98 | 62.50 | 0.48 | N/A | N/A | 73 | +47.56% | $179 | -7.16% | 1.38 |
37 | PTGX | Protagonist Therapeutics Inc | 0.56% | $93.23 | $6.56B | Biotechnology | Healthcare | +1.43% | N/A | 20.08 | N/A | N/A | N/A | 79 | +27.31% | $119 | +21.75% | 0.24 |
38 | ALKS | Alkermes Plc | 0.56% | $41.32 | $6.34B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 41.07 | 111.11 | 1.96 | N/A | N/A | 75 | +9.97% | $45 | +12.36% | 0.66 |
39 | ABVX | Abivax Sa Adr | 0.56% | $72.50 | $10B | Biotechnology | Healthcare | +25.56% | N/A | N/A | N/A | N/A | N/A | 85 | +113.38% | $155 | 0.00% | 1.84 |
40 | RYTM | Rhythm Pharmaceuticals Inc | 0.52% | $84.35 | $6.26B | Biotechnology | Healthcare | +17.00% | N/A | N/A | N/A | N/A | N/A | 79 | +63.84% | $138 | +35.04% | 0.94 |
41 | KYMR | Kymera Therapeutics Inc Ordinary Shares | 0.51% | $71.29 | $6.71B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +65.90% | $118 | +8.70% | 1.55 |
42 | PTCT | Ptc Therapeutics Inc | 0.51% | $68.23 | $5.86B | Biotechnology | Healthcare | -16.59% | N/A | 53.48 | 0.81 | N/A | N/A | 70 | +34.21% | $92 | +12.13% | 1.05 |
43 | MIRM | Mirum Pharmaceuticals Inc | 0.49% | $92.17 | $5.93B | Biotechnology | Healthcare | -34.51% | N/A | 2000.00 | N/A | N/A | N/A | 82 | +56.40% | $144 | +40.23% | 0.90 |
44 | XENE | Xenon Pharmaceuticals Inc | 0.47% | $52.30 | $5.21B | Biotechnology | Healthcare | +40.27% | N/A | N/A | N/A | N/A | N/A | 78 | +51.63% | $79 | +23.02% | 0.95 |
45 | NUVL | Nuvalent Inc Class A | 0.45% | $91.35 | $8.45B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +58.20% | $145 | 0.00% | 1.03 |
46 | TEM | Tempus Ai Inc Class A Common Stock | 0.45% | $49.62 | $8.44B | Health Information Services | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +34.08% | $67 | 0.00% | 2.63 |
47 | SYRE | Spyre Therapeutics Inc | 0.44% | $69.16 | $5.72B | Biotechnology | Healthcare | -2.15% | N/A | N/A | N/A | N/A | N/A | 75 | +37.65% | $95 | -16.21% | 1.74 |
48 | BRKR | Bruker Corp | 0.44% | $57.31 | $7.40B | Medical Devices | Healthcare | N/A | N/A | 15.22 | 1.52 | N/A | N/A | 69 | -12.35% | $50 | -3.20% | 1.22 |
49 | CRSP | Crispr Therapeutics Ag | 0.42% | $52.02 | $5.16B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | N/A | N/A | N/A | -13.88% | N/A |
50 | SRRK | Scholar Rock Holding Corp | 0.42% | $44.68 | $6.03B | Biotechnology | Healthcare | +5.29% | N/A | N/A | N/A | N/A | N/A | 79 | +32.05% | $59 | +10.50% | 0.67 |
IBB (ISHARES BIOTECHNOLOGY ETF) Sector Allocation
HEALTHCARE
94.10%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%